# Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

> **NCT04979884** · PHASE3 · COMPLETED · sponsor: **Alexandria University** · enrollment: 66 (actual)

## Conditions studied

- COVID-19 Acute Respiratory Distress Syndrome
- Cytokine Release Syndrome
- Pulmonary Fibrosis

## Interventions

- **DRUG:** cyclosporine

## Key facts

- **NCT ID:** NCT04979884
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-03
- **Primary completion:** 2022-09-09
- **Final completion:** 2022-12-09
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04979884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04979884, "Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04979884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*